1. Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. (6th January 2021) Authors: Luo, Haibin; Li, Yuling; Robbins, David; Wang, Sheau‐Chiann; Xi, Guoling; Cox, Matthew; Nicholson, Simone M.; Wei, Chenghong; Pabst, Timothy M.; Wang, William K. Journal: Biotechnology progress Issue: Volume 37:Number 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗